Physician profile
Daniel Cusumano
NPI 1871032458
$2,172.69
in general payments reported to CMS, 2019-2025
8 companies · $1,089 in 2025
The $1,089 reported for 2025 was more than what 96% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2021: $12.50 · 2022: $299 · 2023: $76.58 · 2024: $581 · 2025: $1,089.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,137 · Travel and Lodging: $331 · Entertainment: $144 · Gift: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,136.90 |
| Travel and Lodging | $330.96 |
| Entertainment | $144.46 |
| Gift | $135.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Patterson Companies, INC. | $1,274.16 | 2024-2025 | |
| Dentsply Sirona INC | $373.66 | 2019-2023 | Astra Tech Implant System |
| A-Dec, INC. | $319.40 | 2025 | |
| Straumann USA LLC | $83.12 | 2019-2024 | |
| Nobel Biocare USA | $63.29 | 2019-2023 | Nobelactive |
| Philips North America LLC | $30.98 | 2025 | Whitening Pens |
| 3m Company | $15.00 | 2019 | |
| Gc America INC. | $13.08 | 2024 | Mi Paste |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Cusumano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.